Novan Therapeutics landed $78 million from the U.S. Biomedical Advanced Research and Development Authority to further develop the North Carolina-based company's technology that delivers nitric oxide gas to thermal wounds.
The drug, originally approved to treat sleep apnea, had failed another Phase III trial.
Medtronic is officially launching a formal health services arm, with an initial focus on helping European hospitals modernize and better manage their cardiac catheterization labs.
The European Society of Cardiology meeting in Amsterdam produced some notable data for a slate of closely-watched heart drugs over the long weekend.
Taiwanese legislators say they're on the cusp of passing tax cuts and government subsidies to support medical device company R&D and training, something likely to help kickstart further industry growth there.
The degree of neuroinflammation was significantly associated with more severe depression, fatigue and cognitive impairment even after taking into consideration other factors, such as age, gender and disease duration.
Johnson & Johnson ($JNJ) aims to advance antiviral compounds against the rising threat of dengue infection by teaming with Belgian academics whose backing from the Wellcome Trust has aided the discovery of potential drugs against all four strains of the mosquito-borne illness.
The number of rotavirus-related hospitalizations in kids under 5 fell by 80% after the shots went into routine use, and the hospitalizations in kids 5-14 years dropped by 70%.
MIT Technology Review profiles live MRI imaging technology, an advance that's helping to visualize the brain in new ways during neurosurgery. It's also opening doors to some procedures that had been really difficult or off limits.
Scientists have used stem cells to grow the first miniature human brains--called "cerebral organoids"--a major advance that has huge implications for understanding how the brain develops and studying how certain disorders like schizophrenia and autism arise.